RESEARCHERS DISMISS AN AIDS VIRUS DISCOVERY
By John Crewdson
Chicago Tribune 18 Feb. 1988
A 2-year-old claim by scientists
at Harvard University to have discovered a second virus capable of causing
AIDS in humans has been dismissed as "not authentic" in a highly
unusual paper to be published here Thursday by a rival team of Harvard
researchers.
Writing in Nature, the prestigious British scientific journal, scientists
affiliated with Harvard's medical school said neither the purported AIDS
virus, nor another AIDS-type virus said to have been isolated from the
African green monkey, ever really existed.
When they were broken down biologically into their component parts,
the article said, it became evident that the two "new" viruses
were really contaminants of simian immunodeficiency virus, or SIV, which
had been isolated from the rhesus macaque more than a year before.
Because it is unusual for one group of scientists to openly contradict
the work of others, and practically unknown for researchers to investigate
and disprove the work of colleagues at the same institution, the full implications
of the Harvard affair remain to be seen.
One thing that is already clear, however, is that the episode represents
a belated victory for a team of French scientists at the Pasteur Institute
in Paris.
Although the Pasteur team had isolated the second principal human AIDS
virus, now called HIV-2, several months before the Harvard group came up
with its now disproved findings, publication of the Pasteur team's paper
reporting the discovery was apparently held up in the United States to
allow the Harvard team to publish first.
The Harvard affair is also illustrative of what many researchers say
is the undue haste with which much AIDS research is being conducted, partly
out of an urgency to save lives but also because being first to publish
significant new findings carries substantial rewards, financial and otherwise.
It was just a few months after he published his paper on the new human
AIDS virus that Dr. Myron "Max" Essex, the Harvard virologist
in whose laboratory the contaminations occurred, received the Lasker Award,
second in prestige only to the Nobel Prize, for a body of work that included
the two viruses in question.
While more than 40 Lasker Award winners have gone on to become Nobel
laureates, Essex's candidacy for that most sought after of prizes is now
in doubt.
Moreover, the now unavoidable recognition that an American paper containing
erroneous results was published before an earlier French paper containing
accurate results is bound to raise questions about the extent to which
some American scientific and medical journals overlook, or ignore, research
from abroad.
Accompanying the article in Nature is a critique written by Carel Mulder,
a professor of microbiology at the University of Massachusetts.
In unusually stern language for a scholarly journal, Mulder writes,
"This episode should serve as a strong warning for all virologists
working with multiple isolates (of different viruses) to check any new
isolates against viruses present in the laboratory."
Mulder also hints at larger problems on the horizon when he writes,
"I am aware, or have been told, of at least five instances in other
laboratories in the United States and Europe where non-infected cell cultures
became infected with HIV-1," the principal virus believed to cause
acquired immune deficiency syndrome (AIDS) in humans.
Although there is only one reported case of HIV-2 infection in the U.S.,
it is now the predominant AIDS virus in western Africa.
The Nature article contains an unusual reply by Essex and one of his
coworkers, Phyllis Kanki, in which they "acknowledge the results of
others and agree that certain isolates initially reported by us . . . should
be considered SIV unless proven otherwise."
When the "new" AIDS virus was announced by Essex and Kanki,
it appeared in an article in the April 13, 1986, issue of Science, the
journal of the American Association for the Advancement of Science. The
same publication carried the group's report of the green monkey virus a
few months before. The new AIDS virus, the article said, had been found
in blood samples taken from "apparently healthy people in Senegal,
west Africa."
It seemed, at first, one of the most promising and important discoveries
in the panoply of AIDS research. Because the second AIDS virus was nearly
identical biologically to the purported green monkey virus, the authors
suggested that the similarities "may expand our understanding"
of the origin of the human AIDS virus.
The highly publicized article led to broad speculation about the possibility
that the human AIDS virus had originated in African monkeys and then been
passed somehow across the "species barrier" into humans.
Although the Essex-Kanki article was published in Science less than
three months after it was received by the journal's editors, the article
from the Pasteur Institute about the isolation of what has since proved
to be the genuine HIV-2 did not appear until July of 1986, more than 13
months after it was submitted for publication.
Editors at Science failed Tuesday to return a telephone call from a
reporter seeking information about why the French article was withheld
from publication for so many months, and whether the journal would now
publish a retraction or correction.
Because of the intra-institutional rivalries involved-sources said the
Essex affair had bruised egos and strained friendships at Harvard-no one
involved in disproving the Essex research would agree to be quoted by name.
But several of those with knowledge provided the following account of events:
In 1985 scientists at the New England Primate Research Center, an adjunct
of Harvard Medical School, isolated the virus they called SIV from a group
of captive rhesus macaques, which are classified as Asian old world primates.
The researchers at the primate center sent a sample of SIV to the Essex
laboratory at the Harvard School of Public Health, with the understanding
that workers there were interested in studying the biological makeup of
the virus.
The Essex laboratory, meanwhile, had discovered that nearly half of
African green monkeys possessed chemical evidence of an infection with
a virus not unlike SIV, and researchers there began trying to isolate a
variant of SIV from that species.
Nine samples of green monkey blood were obtained from a primate center
on Long Island, and within a matter of days the Essex team had isolated
what it was calling a new simian immune-deficiency virus from eight of
the nine.
A few months later, the Essex lab reported that it had isolated a new
human AIDS virus that was remarkably similar to the green monkey virus
from the west African human blood samples.
Replication is the touchstone of science, and the first doubts about
the Essex findings occurred when scientists in other labs, including those
at the primate research center, were unable in independent experiments
to isolate either of the two new viruses.
Then, when samples of each of the new viruses were compared with other
samples of the same virus, they proved to be far more alike than would
be expected to have occurred in nature.
But the real concern began to develop when workers at the primate center
compared the green monkey virus with the new AIDS virus directly-and found
that they, too, were not only similar but virtually identical.
When both those viruses also proved to be identical to the sample of
SIV that the primate center researchers had originally lent to the Essex
lab, it became clear that a major contamination had occurred.
Researchers agree that the threat of laboratory contamination-the possibility
that a virus from one dish or flask will somehow invade a culture in another
dish or flask-is a constant worry.
But they also agree that proper laboratory procedures can lessen such
concerns. They add that when a contamination is suspected, and especially
before an important new virus is announced, routine checks should be performed
in which the new virus is compared with existing viruses in the laboratory.
If Essex and his coworkers ever performed such a comparison, they never
announced the results. Indeed, some of those familiar with a meeting at
the Pasteur Institute last fall say he continued to deny the possibility
of a cellular contamination.
"We had to do something," said one of the scientists involved
in disproving the Essex research. "Already 21 or 22 other articles
had been published that were drawing on his paper."
Ironically it was only after another two years of work that the primate
center researchers were able to report that they had finally isolated a
true variant of SIV from the blood of the African green monkey. *